TESSERA combines LLMs as local policy and evaluator with MCTS on knowledge graphs to compose mechanistic drug-disease explanations.
Title resolution pending
3 Pith papers cite this work. Polarity classification is still indexing.
3
Pith papers citing it
citation-role summary
dataset 1
citation-polarity summary
years
2026 3roles
dataset 1polarities
use dataset 1representative citing papers
Starling uses LLMs and agents to turn 22.5M PubMed papers into 6.3M nuanced structured records across six tasks with 0.6-7.7% frontier-model rejection rates, lower than error rates on existing curated databases.
Boltz-2 and fine-tuned DrugFormDTA lead ML-based binding prediction while GNINA leads docking tools on a cleaned antiviral dataset, with performance varying by viral protein.
citing papers explorer
-
LLM-Guided Monte Carlo Tree Search over Knowledge Graphs: Composing Mechanistic Explanations for Drug-Disease Pairs
TESSERA combines LLMs as local policy and evaluator with MCTS on knowledge graphs to compose mechanistic drug-disease explanations.
-
Self Driving Datasets: From 20 Million Papers to Nuanced Biomedical Knowledge at Scale
Starling uses LLMs and agents to turn 22.5M PubMed papers into 6.3M nuanced structured records across six tasks with 0.6-7.7% frontier-model rejection rates, lower than error rates on existing curated databases.
-
Benchmarking open-source tools for in silico antiviral drug discovery
Boltz-2 and fine-tuned DrugFormDTA lead ML-based binding prediction while GNINA leads docking tools on a cleaned antiviral dataset, with performance varying by viral protein.